Hepatocellular Cancer
90
15
20
34
Key Insights
Highlights
Success Rate
65% trial completion
Published Results
20 trials with published results (22%)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
20.0%
18 terminated out of 90 trials
65.4%
-21.1% vs benchmark
3%
3 trials in Phase 3/4
59%
20 of 34 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 34 completed trials
Clinical Trials (90)
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers
Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
A Longitudinal Observational Study of the Natural History and Management of Patients With HCC
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
Volatile Organic Compounds for the Assessment of Liver Disease
A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)
Combined Treatment of Durvalumab, Bevacizumab, Tremelimumab and Transarterial Chemoembolization (TACE) in Subjects With Hepatocellular Carcinoma or Biliary Tract Carcinoma
GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor Malignancies
Effect of Pregabalin on the Postoperative Analgesia in RFA of Focal Lesions in the Liver
Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With Pembrolizumab in Patients With Selected Advanced Solid Tumors
Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic Cancers
The PLATON Network
Yttrium-90 Radiation Segmentectomy for Hepatocellular Carcinoma
A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Survey of Cabozantinib Tablets Used To Treat People With Hepatocellular Carcinoma
ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk
A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors
Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow
Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC